Moderna Initiates Phase 3 Portion of Pivotal Trial for mRNA Respiratory Syncytial Virus (RSV)…
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Data and Safety Monitoring Board (DSMB) for the RSV program has…
Read More...
Read More...
